These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8649254)

  • 1. [Vaccines blocking transmission].
    Sauerwein R
    Med Trop (Mars); 1995; 55(4 Suppl):118. PubMed ID: 8649254
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.
    Saxena AK; Wu Y; Garboczi DN
    Eukaryot Cell; 2007 Aug; 6(8):1260-5. PubMed ID: 17557884
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis of malaria: characterization of a protective surface antigen.
    Nussenzweig RS; Nussenzweig V
    Harvey Lect; 1982-1983; 78():59-85. PubMed ID: 6151556
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosquito stage, transmission blocking vaccines for malaria.
    Saul A
    Curr Opin Infect Dis; 2007 Oct; 20(5):476-81. PubMed ID: 17762780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target antigens of malaria transmission blocking immunity.
    Kaushal DC; Carter R; Miller LH
    J Commun Dis; 1987 Dec; 19(4):417-21. PubMed ID: 3507450
    [No Abstract]   [Full Text] [Related]  

  • 8. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy.
    Kongkasuriyachai D; Bartels-Andrews L; Stowers A; Collins WE; Sullivan J; Sattabongkot J; Torii M; Tsuboi T; Kumar N
    Vaccine; 2004 Aug; 22(23-24):3205-13. PubMed ID: 15297075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria vaccines: scientific and ethical issues.
    Tosta CE
    Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S33-40. PubMed ID: 1340632
    [No Abstract]   [Full Text] [Related]  

  • 10. The 'do unto others' malaria vaccine.
    Vogel G
    Science; 2010 May; 328(5980):847-8. PubMed ID: 20466919
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
    Chirkov VP; Popov AF
    Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
    [No Abstract]   [Full Text] [Related]  

  • 12. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria vaccines: if at first you don't succeed..
    Tongren JE; Zavala F; Roos DS; Riley EM
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting dilution analysis of antigen-specific CD4+ T-cell responses in mice.
    Seixas E; Langhorne J; Quin S
    Methods Mol Med; 2002; 72():385-99. PubMed ID: 12125134
    [No Abstract]   [Full Text] [Related]  

  • 15. Mosquito-based transmission blocking vaccines for interrupting Plasmodium development.
    Lavazec C; Bourgouin C
    Microbes Infect; 2008 Jul; 10(8):845-9. PubMed ID: 18656409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in mice.
    Tachibana M; Baba M; Takashima E; Tsuboi T; Torii M; Ishino T
    Vaccine; 2020 Mar; 38(15):3129-3136. PubMed ID: 32147299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria vaccines getting close to clinical reality.
    Sauerwein RW; Richie TL
    Vaccine; 2015 Dec; 33(52):7423-4. PubMed ID: 26518403
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines against malaria - an update.
    Matuschewski K; Mueller AK
    FEBS J; 2007 Sep; 274(18):4680-7. PubMed ID: 17824954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria vaccines: multiple targets.
    Nussenzweig RS; Long CA
    Science; 1994 Sep; 265(5177):1381-3. PubMed ID: 8073276
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress towards a malaria vaccine.
    Ramasamy R
    Indian J Malariol; 1987 Jun; 24(1):1-7. PubMed ID: 3326750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.